12 / 33
Page 39
Notes:
conferenceseries
.com
Volume 3, Issue 3 (Suppl)
J Kidney, an open access journal
ISSN:2472-1220
Kidney & Nephrology 2017
August 28-30, 2017
August 28-30, 2017 Philadelphia, USA
15
th
Annual Congress on
Kidney: Nephrology & Therapeutics
Medicare telehealth service and nephrology: Policies for eligibility and payment
Stephanie Frilling
Social & Scientific Systems Inc, USA
T
here are just over 80 professional physician or practitioner services that may be furnished via telehealth, defined by
medicare as interactive audio and video telecommunications systems that permit real-time communication between a
beneficiary at the originating site and the provider at the distant site. These services include 16 nephrology billing codes for
furnishing end-stage renal disease services for monthly monitoring and assessment, and two billing codes for chronic kidney
disease education. In recent years, many mobile health devices and other web based tools have been developed in support of
monitoring, observation and collaboration for people living with chronic disease. However, digital health devices often do not
meet telehealth conditions for coverage as currently required under medicare. The criteria for furnishing telehealth nephrology
services, as well as, all other medicare telehealth services are set forth in section 1834(m) of the social security act. Telehealth
services are paid under medicare part b, when furnished via a telecommunications system that substitutes for an in-person
encounter. The presentation will review the statutory and program guidance that govern medicare telehealth services, defines
payment policy terms, (such as originating site and distance site) and clarifies payment policies when telehealth services are
furnished, discuss innovation and other technological advancements in telehealth and neprology, and medicare’s program
authority and other statutory inciatives for enhancing the telehealth benefit.
Biography
Stephanie frilling, MBA, MPH, is currenlty the Program Lead for the skilled nursing facility value-based purchaing program and the monitoring and valuation lead
for CMS’s value incentives quality reporting programs. As a program lead, she is responsible for overseeing all aspects of regulatory and health policy issuse for
these programs, which are opertated by the centers for quality standards and quality. During her tenure at CMS, she has also served as the Program Lead for
the end-stage renal disease quality incentive program, and as a subject matter expert for the physican fee scheudle and the end-stage renal disease prospective
payment system, and has extensive payment experience with medicare payment and quality programs. She holds an MBA, MPH and is currently pursuing a
Doctrate in Bioethics from Loyola of chicago.
sfrilling@s-3.comStephanie Frilling, J Kidney 2017, 3:3 (Suppl)
DOI: 10.4172/2472-1220-C1-002